shanghai fosun pharma

After opening at ₹1,710, a 14% premium to the issue price of ₹1,500, the stock rose further to close at ₹1,828, a 21.86% gain from the issue price.(PTI Photo)

Gland Pharma makes a stellar market debut

By Nasrin Sultana | Livemint, Mumbai
PUBLISHED ON NOV 21, 2020 03:30 AM IST
China’s Shanghai Fosun Pharma acquired a 74% stake in Gland Pharma in 2017 for more than $1.1 billion, in the largest acquisition of an Indian company by a Chinese firm.
Story Saved